MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$3,706K
EPS
-$0.21
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
Research and development
-4,288
23,277
Restructuring and impairment
-
17,486
General and administrative
8,254
8,079
Total operating expenses
3,966
48,842
Operating loss
-3,966
-48,842
Other income
260
860
Net loss
-3,706
-47,982
Unrealized (loss) gain on marketable securities
-
-1
Other comprehensive (loss) gain
-
-1
Comprehensive loss
-3,706
-47,983
Basic EPS
-0.21
-2.78
Diluted EPS
-0.21
-2.78
Basic Average Shares
17,321,544
17,271,518
Diluted Average Shares
17,321,544
17,271,518
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$3,706K
Net loss
-$3,706K
Other income
$260K
Operating loss
-$3,966K
Total operating
expenses
$3,966K
Research and development
-$4,288K
General and
administrative
$8,254K
Buy us a coffee
Mural Oncology plc (MURA)
Mural Oncology plc (MURA)